Imaging Facilities

Facilitating high quality research that will inform the identification of effective new treatment


The Imaging Facilities is part of the Faculty of Biology, Medicine and Health.

We have specific expertise in neuro-imagingneuro-oncologydementiaoncology, musculoskeletal and cardiovascular imaging but also perform imaging on a range of other disease areas.

Based at sites across Greater Manchester, we have clinical PET-MR and MR scanners and  also offer pre-clinical PET and MR imaging opportunities at WMIC and our lab on the main University campus.

Training and education

Colleagues in the Faculty of Biology, Medicine and Health contribute to a taught Masters programme in Medical Imaging Science.

We also welcome PhD students in the Faculty and offer a PhD/DPhil programme in Biomedical Imaging Sciences.


We are involved in a wide range of research activities; here’s a snapshot:

MRC – Dementias Platform UK initiative (DPUK)

The University was awarded £6 million in October 2014 as part of the Prime Minister’s Dementias Platform UK initiative and one element of this award funded the purchase and installation of a new PET-MR scanner.

The scanner is housed in the Nuclear Medicine department at St Mary’s Hospital in Manchester and is available for research scanning now. This is an exciting development for the University’s Imaging Facilities, as it is one of just seven PET-MR scanners in the UK – and the only one in the North-West.

MRC/NIHR – Deep and Frequent Phenotyping Study (DPUK)

The University of Manchester is a partner in this multi-centre study which has been designed to identify measureable characteristics, known as biomarkers, which can detect the occurrence of Alzheimer’s disease very early on in the progression of the disease. The study will use [18F] Florbetapir across the seven PET-MR scanners in the UK. WMIC will be manufacturing the tracer for the Manchester PET-MR scans.

The PI for this study is Dr Iracema Leroi

MRC DPUK MR-PET Harmonisation study

This is a multi-centre study led by Prof Karl Herholz and aims to harmonise and quantify the repeatability and reproducibility of regional [18F] Florbetapir brain measurements using the seven PET-MR scanners in the UK. This study is badged under the Dementias Platform UK initiative and WMIC will be manufacturing the tracer for the Manchester PET-MR scans.


For general information on using the Facilities, please contact:

Denise Ogden
Senior Business Operations Manager
Wolfson Molecular Imaging Centre
The University of Manchester
27 Palatine Road
M20 3LJ
T: +44 (0) 161 275 0017